Adalimumab

Details

Files

Generic Name:

Adalimumab

Project Status:

Complete

Therapeutic Area:

Crohn's disease

Manufacturer:

Abbott Laboratories, Limited

Brand Name:

Humira

Project Line:

Reimbursement Review

Project Number:

SR0105-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Resubmission

Indications:

Crohn's disease

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

December 19, 2007

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Summary of CEDAC Discussion View PDF

Overview of CDR Reports View PDF

Plain Language Recommendation View PDF

Last Updated : July 12, 2007